A curator of the Victoria and Albert Museum’s “Cartier” exhibition explains how the jeweler’s “elegance” and “discretion” led ...

At the core of his ongoing rift with other members of the royal family is Harry’s belief that the removal of security was a tactic to force him and Meghan to return to their former royal roles ...

HELLO! brings you the latest news, photos and exclusives from the British Royal Family as they happen. The British royals are well-known for their charity work and public support of numerous ...

Sandhurst has a special connection to the royal family — it's where brothers Prince William and Prince Harry had their military training. During an appearance at the military parade in 2023 ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...

A long-acting Factor VIII replacement therapy for haemophilia A from Sobi and Sanofi has been recommended for use by the NHS and could allow patients to reduce the number of injections they need ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia. The recommendation by the EMA's ...

Sanofi R&D in its core haemophilia category is advancing on three fronts – engineered proteins, RNA interference drugs and gene therapies – and highlighted results in two of those at the ...

There has been a gene therapy on the market for people with the bleeding disorder haemophilia A since 2022, but take-up has been very slow. Pfizer and Sangamo are hoping for a faster trajectory ...